Published in Pharmacol Res on August 11, 2013
Microglial cell dysregulation in brain aging and neurodegeneration. Front Aging Neurosci (2015) 0.92
Microglia regulate blood clearance in subarachnoid hemorrhage by heme oxygenase-1. J Clin Invest (2015) 0.92
Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Transl Res (2015) 0.90
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors. Cancer Biol Ther (2014) 0.88
Neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by sulforaphane by promoting M2 polarization of microglia. J Neuroinflammation (2016) 0.84
Heme Oxygenases in Cardiovascular Health and Disease. Physiol Rev (2016) 0.82
Hyperammonemia induces glial activation, neuroinflammation and alters neurotransmitter receptors in hippocampus, impairing spatial learning: reversal by sulforaphane. J Neuroinflammation (2016) 0.81
Expression and contributions of TRPM7 and KCa2.3/SK3 channels to the increased migration and invasion of microglia in anti-inflammatory activation states. PLoS One (2014) 0.81
Fumaric acid esters can block pro-inflammatory actions of human CRP and ameliorate metabolic disturbances in transgenic spontaneously hypertensive rats. PLoS One (2014) 0.79
Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis. Ann Clin Transl Neurol (2015) 0.78
Carnosol: a phenolic diterpene with cancer chemopreventive potential. J Cancer Prev (2014) 0.78
Inhibition of microglial activation by elderberry extracts and its phenolic components. Life Sci (2015) 0.78
TSPO Finds NOX2 in Microglia for Redox Homeostasis. Trends Pharmacol Sci (2016) 0.78
Nrf2 knockout attenuates the anti-inflammatory effects of phenethyl isothiocyanate and curcumin. Chem Res Toxicol (2014) 0.77
Agmatine Reduces Lipopolysaccharide-Mediated Oxidant Response via Activating PI3K/Akt Pathway and Up-Regulating Nrf2 and HO-1 Expression in Macrophages. PLoS One (2016) 0.76
Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease. Exp Biol Med (Maywood) (2015) 0.76
The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2. Antioxid Redox Signal (2017) 0.76
Fumarate modulates the immune/inflammatory response and rescues nerve cells and neurological function after stroke in rats. J Neuroinflammation (2016) 0.75
Hypoxia-Inducible Factor-1α Target Genes Contribute to Retinal Neuroprotection. Front Cell Neurosci (2017) 0.75
The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer's Disease. Evid Based Complement Alternat Med (2016) 0.75
Anti-neuroinflammatory Activity of Elephantopus scaber L. via Activation of Nrf2/HO-1 Signaling and Inhibition of p38 MAPK Pathway in LPS-Induced Microglia BV-2 Cells. Front Pharmacol (2017) 0.75
Isoliquiritigenin in licorice functions as a hepatic protectant by induction of antioxidant genes through extracellular signal-regulated kinase-mediated NF-E2-related factor-2 signaling pathway. Eur J Nutr (2015) 0.75
Cyclosporine before PCI in Patients with Acute Myocardial Infarction. N Engl J Med (2015) 5.90
Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J (2003) 3.00
Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial. JAMA (2009) 2.72
Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res (2003) 2.34
Effects of polycythemia on systemic endothelial function in chronic hypoxic lung disease. J Appl Physiol (1985) (2011) 2.04
[Senile systemic amyloidosis: definition, diagnosis, why thinking about?]. Presse Med (2013) 2.00
Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 1.87
CORM-3, a carbon monoxide-releasing molecule, alters the inflammatory response and reduces brain damage in a rat model of hemorrhagic stroke. Crit Care Med (2012) 1.80
Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol (2005) 1.80
Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction. J Mol Cell Cardiol (2012) 1.69
Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule. Am J Physiol Renal Physiol (2005) 1.68
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. Br J Clin Pharmacol (2012) 1.62
Prognostic significance and normal values of 2D strain to assess right ventricular systolic function in chronic heart failure. Circ J (2011) 1.60
Alterations of systolic left ventricular twist after acute myocardial infarction. Am J Physiol Heart Circ Physiol (2002) 1.59
Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 1.57
Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol (2004) 1.56
Prognostic value of chronic kidney disease after transcatheter aortic valve implantation. J Am Coll Cardiol (2013) 1.55
Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J Biol Chem (2005) 1.50
Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J (2005) 1.49
Comparison of four right ventricular systolic echocardiographic parameters to predict adverse outcomes in chronic heart failure. Eur J Heart Fail (2009) 1.48
Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal (2003) 1.44
Metal fume fever. Lancet (2013) 1.43
Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci (2002) 1.41
Ambulatory transradial percutaneous coronary intervention: a safe, effective, and cost-saving strategy. Catheter Cardiovasc Interv (2012) 1.39
Carbon monoxide rescues mice from lethal sepsis by supporting mitochondrial energetic metabolism and activating mitochondrial biogenesis. J Pharmacol Exp Ther (2009) 1.38
Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer. Stem Cells (2011) 1.38
Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. J Biol Chem (2008) 1.30
Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal (2002) 1.29
Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br J Pharmacol (2004) 1.28
Biosimilar drugs : concerns and opportunities. BioDrugs (2007) 1.26
Use of carbon monoxide as a therapeutic agent: promises and challenges. Intensive Care Med (2008) 1.25
Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Surv Ophthalmol (2002) 1.24
CO-metal interaction: Vital signaling from a lethal gas. Trends Biochem Sci (2006) 1.22
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Neuropsychopharmacology (2008) 1.21
The use of antidepressant drugs and the lifetime prevalence of major depressive disorders in Italy. Clin Pract Epidemiol Ment Health (2010) 1.20
Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity. J Immunol (2009) 1.19
Metal carbonyls: a new class of pharmaceuticals? Angew Chem Int Ed Engl (2003) 1.19
Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability. Pharm Res (2003) 1.17
Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. Eur J Pharmacol (2009) 1.16
Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. Learn Mem (2009) 1.16
Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol (2004) 1.12
Carbon monoxide-releasing antibacterial molecules target respiration and global transcriptional regulators. J Biol Chem (2008) 1.12
Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients. Invest Ophthalmol Vis Sci (2005) 1.12
Interaction of bilirubin and biliverdin with reactive nitrogen species. FEBS Lett (2003) 1.11
cGMP produced by NO-sensitive guanylyl cyclase essentially contributes to inflammatory and neuropathic pain by using targets different from cGMP-dependent protein kinase I. J Neurosci (2008) 1.10
Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure. Eur Heart J (2010) 1.09
A carbon monoxide-releasing molecule (CORM-3) uncouples mitochondrial respiration and modulates the production of reactive oxygen species. Free Radic Biol Med (2011) 1.08
Single-beat versus multibeat real-time 3D echocardiography for assessing left ventricular volumes and ejection fraction: a comparison study with cardiac magnetic resonance. Circ Cardiovasc Imaging (2010) 1.07
Protective effects of a coumarin derivative in diabetic rats. Invest Ophthalmol Vis Sci (2009) 1.06
A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia. FASEB J (2008) 1.06
Isoflavones: estrogenic activity, biological effect and bioavailability. Eur J Drug Metab Pharmacokinet (2013) 1.05
Metal carbonyls as pharmaceuticals? [Ru(CO)3Cl(glycinate)], a CO-releasing molecule with an extensive aqueous solution chemistry. Dalton Trans (2007) 1.05
Incomplete resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction after stenting for acute myocardial infarction. Circulation (2003) 1.05
Chemistry and biological activities of CO-releasing molecules (CORMs) and transition metal complexes. Dalton Trans (2007) 1.04
TGF-beta 1 protects against Abeta-neurotoxicity via the phosphatidylinositol-3-kinase pathway. Neurobiol Dis (2008) 1.04
Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade. Eur J Pharmacol (2003) 1.03
Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension. Am J Respir Cell Mol Biol (2013) 1.02
Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression. Eur Neuropsychopharmacol (2010) 1.02
Induction of heme oxygenase 1 by nitrosative stress. A role for nitroxyl anion. J Biol Chem (2002) 1.01
Potential role of probiotics on colorectal cancer prevention. BMC Surg (2012) 1.01
Antioxidants as antidepressants: fact or fiction? CNS Drugs (2012) 1.00
Prevalence of, associations with, and prognostic value of tricuspid annular plane systolic excursion (TAPSE) among out-patients referred for the evaluation of heart failure. J Card Fail (2012) 0.99
CO and NO in medicine. Chem Commun (Camb) (2007) 0.99
Pharmacological management of ocular hypertension: current approaches and future prospective. Curr Opin Pharmacol (2012) 0.99
Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Biochem Pharmacol (2012) 0.99
Simple determination of riluzole in rat brain by high-performance liquid chromatography and spectrophotometric detection. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.99
Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling. Pflugers Arch (2014) 0.98
Differential activation of heme oxygenase-1 by chalcones and rosolic acid in endothelial cells. J Pharmacol Exp Ther (2004) 0.98
Carbon monoxide-releasing molecules modulate leukocyte-endothelial interactions under flow. J Pharmacol Exp Ther (2007) 0.98
Red orange: experimental models and epidemiological evidence of its benefits on human health. Oxid Med Cell Longev (2013) 0.98
Mediterranean diet and cancer: epidemiological evidence and mechanism of selected aspects. BMC Surg (2013) 0.97
Generation of bile pigments by haem oxygenase: a refined cellular strategy in response to stressful insults. Biochem Soc Symp (2004) 0.97
Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules. Antioxid Redox Signal (2011) 0.97
Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium. J Mol Cell Cardiol (2011) 0.97
Endocannabinoids and neurodegenerative diseases. Pharmacol Res (2007) 0.97
Nanotubular crosstalk with distressed cardiomyocytes stimulates the paracrine repair function of mesenchymal stem cells. Stem Cells (2014) 0.97
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats. J Pharmacol Exp Ther (2007) 0.97
Sigma receptor ligands protect human retinal cells against oxidative stress. Neuroreport (2006) 0.97
Comparison of real-time three-dimensional speckle tracking to magnetic resonance imaging in patients with coronary heart disease. Am J Cardiol (2011) 0.96
Heme oxygenase-1 mediates the anti-inflammatory actions of 2'-hydroxychalcone in RAW 264.7 murine macrophages. Am J Physiol Cell Physiol (2005) 0.96
TGF-β1 pathway as a new target for neuroprotection in Alzheimer's disease. CNS Neurosci Ther (2009) 0.96
Glutathione deficiency in cardiac patients is related to the functional status and structural cardiac abnormalities. PLoS One (2009) 0.96
Prognostic impact of sleep-disordered breathing and its treatment with nocturnal ventilation for chronic heart failure. Eur J Heart Fail (2012) 0.96
Carbon monoxide improves cardiac function and mitochondrial population quality in a mouse model of metabolic syndrome. PLoS One (2012) 0.96
Dysfunction of TGF-β1 signaling in Alzheimer's disease: perspectives for neuroprotection. Cell Tissue Res (2011) 0.95
The lifetime prevalence of bipolar disorders and the use of antidepressant drugs in bipolar depression in Italy. J Affect Disord (2011) 0.95
Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Cardiovasc Res (2006) 0.94
Laparoscopic vs. open approach for colorectal cancer: evolution over time of minimal invasive surgery. BMC Surg (2013) 0.94
Carbon monoxide rapidly impairs alveolar fluid clearance by inhibiting epithelial sodium channels. Am J Respir Cell Mol Biol (2009) 0.94
Carbon monoxide reduces neuropathic pain and spinal microglial activation by inhibiting nitric oxide synthesis in mice. PLoS One (2012) 0.94
The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med (2013) 0.93
Effects of HIV protease inhibitors on progression of monocrotaline- and hypoxia-induced pulmonary hypertension in rats. Circulation (2010) 0.93
Measuring left ventricular function in the normal, infarcted and CORM-3-preconditioned mouse heart using complex admittance-derived pressure volume loops. J Pharmacol Toxicol Methods (2008) 0.93
Endocannabinoid system and mood disorders: priming a target for new therapies. Pharmacol Ther (2012) 0.93
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. Front Behav Neurosci (2011) 0.93